LO WILLIAM WING YAN DR 4

What Happened Dr. William Wing Yan Lo, a director of Regencell Bioscience Holdings Ltd (RGC), reported a disposition to the issuer of options covering 70,600 ordinary shares on May 27, 2026. The company repurchased the options at $15.00 per option. The filing indicates the aggregate repurchase payment to Dr. Lo was reduced by the aggregate exercise price of the repurchased options (see footnotes).

Key Details

• Transaction date: May 27, 2026 (reported on Form 4 filed May 29, 2026). Transaction code: D (Disposition to issuer).
• Quantity: 70,600 options covering ordinary shares.
• Repurchase price: $15.00 per option (aggregate consideration further reduced by the options' aggregate exercise price).
• Derivative transaction: Yes — this was an option repurchase, not an open-market sale of underlying shares.
• Exercise-price adjustment: Footnote notes exercise price has been adjusted for any share splits since grant.
• Shares owned after transaction: Not specified in the filing.
• Filing timeliness: Report filed within two business days of the transaction (not indicated as late).

Context This was a derivative disposition (issuer repurchase of options). That means the company bought back option rights from the director; it does not necessarily reflect a sale of previously held underlying shares. The filing is factual and does not state the director’s motivation.